We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Patients who tested positive for peripheral artery disease (PAD) when screened using Selmer Scientific’s QuantaFlo in-home test showed significantly increased cardiac and adverse limb events in the follow-up period, according to a study reported in the peer-reviewed journal AJPM Focus. Read More
Valo Health announced positive results of a five-year collaboration with the FDA to study the potential of cardiac contractility modulation (CCM) to treat heart failure patients using human engineered cardiac tissues to assess the device’s safety.
C2N Diagnostics announced the planned launch of its new diagnostic blood test, PrecivityAD2, which uses mass spectrometry and a statistical algorithm to detect the two key drivers behind Alzheimer’s disease — tau and amyloid beta proteins. Read More
Women with breast or ovarian cancer had fewer hot flashes, less psychiatric distress and better quality of life after using XRHealth’s virtual reality (VR)-artificial intelligence (AI)- based technology, researchers reported in the journal Healthcare. Read More
A research team in Massachusetts has developed a “deep learning” tool that can search cardiac X-rays (CXR) to find patterns associated with atherosclerotic cardiovascular disease (CVD), accurately predicting major cardiac events over the span of 10 years, according to study results presented at the Radiological Society of North America meeting in Chicago, Nov. 27-Dec. 1. Read More
John Hopkins Kimmel Cancer Center in Baltimore, Md., used artificial intelligence (AI) blood test technology to detect more than 80 percent of liver cancers in current liver cancer and at-risk patients. Read More